30
Growth Score in past quarter
pts
Heat Score 30 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1187999
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells
Sandra Van Wetering: VP Process Science and ManufacturingPast Role: DCPrime, Chief Operations Officer- Adrian Hayday: Co-Founder
About the Company
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.


